The introduction of the α-synuclein (a-syn) cerebrospinal fluid (CSF) seeding amplification assay (SAA) offers a promising approach for the diagnosis of Parkinson’s disease (PD) and other synucleinopathies. This evidence concerns the gene SNCA and Parkinson disease.